Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. The MedCitizens are sponsored by MyPRGenie, the only Do-It-Yourself, PR platform and news wire that gives you access to more than 540,000 journalist contacts.
Now here’s the best of what YOU had to say:
- Boston Scientific finishes acquisition of catheter firm. “Asthmatx Inc. is now a wholly-owned subsidiary of Boston Scientific Corp. (NYSE:BSX).”
- InVivo Therapeutics has regenerative answer to spinal cord injury. “InVivo Therapeutics Corp. (OTC:NVIV) closed a reverse merger with its holding company, taking itself public under the stock symbol “NVIV” on the OTC exchange as of tomorrow.”
- Healthcare mobile apps: A quick look at DynaMed. “I knew about most of the ones she talked about: Epocrates, Clini-eGuide, PubMed on Tap, PubMed for Handhelds, and RefWorks. Of those, I only use Epocrates. The one I didn’t know was the first one she highlighted: Dynamed (the actual app is Skyscape).”
- House calls making a comeback? “The doctor will see you now … in your home.”
